“…Individuals with sequence variants that allow residual OTC activity can present with hyperammonemia at any point in life, while others remain asymptomatic. In patients with late onset OTCD, acute hyperammonemia can be triggered by a high protein meals (Ben-Ari et al, 2010; Thurlow et al, 2010; Cavicchi et al, 2014), fasting (Marcus et al, 2008), infections (McGuire et al, 2013), invasive medical procedures (Chiong et al, 2007; Hu et al, 2007; Bezinover et al, 2010), chemotherapy (Lipskind et al, 2011; Cavicchi et al, 2014), or other environmental insults that result in increased protein catabolism and ammonia production (Seminara et al, 2010). Missense mutations that cause partial OTCD reduce OTC enzymatic activity or stability while mutations in the vicinity of consensus splice sites can potentially affect mRNA processing and result in decreased abundance of the OTC enzyme.…”